IHL 0.00% 4.1¢ incannex healthcare limited

If I'm not mistaken this Ph1 trial should give us some strong...

  1. 872 Posts.
    lightbulb Created with Sketch. 467
    If I'm not mistaken this Ph1 trial should give us some strong efficacy signals too? I believe the main aim was to ensure no adverse reaction when combining the constituent substances making up IHL-675A.

    Should be the start of unlocking another significant market if successful. I know focus has been on OSA but isn't the market potential for IHL-675A actually larger?
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.